Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
Main Authors: | Takuma Higurashi, Jun Arimoto, Atsushi Nakajima, Keisuke Ariyoshi, Shunsuke Oyamada, Masataka Taguri, Masato Yoneda, Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, Tomoyuki Iwasaki, Takeo Kurihashi, Michihiro Iwaki, Kunihiro Hosono, Eiji Sakai, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Yuki Kasai, Tsutomu Yoshihara, Noboru Misawa, Takayuki Kato, Akiko Fuyuki, Hideyuki Chiba, Machiko Nakatogawa, Ayao Suzuki, Noritoshi Kobayashi, Yasushi Ichikawa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-05-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/5/e060704.full |
Similar Items
-
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation
by: Atsushi Yamamoto, et al.
Published: (2022-08-01) -
Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol
by: Tsutomu Yoshihara, et al.
Published: (2022-12-01) -
Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD
by: Asako Nogami, et al.
Published: (2022-12-01) -
Prior appendectomy and cerebral infarction as potential risk factors for recurrent ischemic colitis: A retrospective observational study
by: Tomohiro Takatsu, et al.
Published: (2023-08-01) -
Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial
by: Anna Ozaki, et al.
Published: (2022-04-01)